NRAS and melanoma: In similar experiments, we found that although combining JQ‐1 with the CDK4/6 inhibitor, PD991, appeared to be effective in NRAS‐mutant melanoma (Fig EV2, and Appendix Fig S4A and B), this combination significantly inhibited the proliferation of non‐transformed cells (Appendix Fig S4B).